Cogstate Ltd ( (AU:CGS) ) has provided an announcement.
Cogstate Ltd has announced an update on its ongoing on-market buy-back program, with a total of 177,352 ordinary fully paid securities bought back on the previous day, adding to the cumulative total of 2,335,585 securities. This buy-back initiative is part of Cogstate’s strategy to optimize its capital structure, potentially enhancing shareholder value and reflecting confidence in the company’s financial health.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in cognitive science and technology. The company provides cognitive assessment services and tools, focusing on enhancing clinical trials and healthcare research.
YTD Price Performance: 22.22%
Average Trading Volume: 9,438
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $154.5M
Learn more about CGS stock on TipRanks’ Stock Analysis page.